Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Levy

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Trials|November 22, 2019
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trialClara Sanches, Richard Levy, Sarah Benisty, et al.
Cancer Research Communications|March 16, 2023
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 RechallengeAndre van der Westhuizen, Megan Lyle, Moira C Graves, et al.
The Journal of Prevention of Alzheimer'S Disease|January 29, 2025
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI DetectionJulien Dumurgier, Claire Paquet, Jacques Hugon, et al.
Brain : a Journal of Neurology|April 15, 2016
Reasoning by analogy requires the left frontal pole: lesion-deficit mapping and clinical implicationsMarika Urbanski, Marie-Laure Bréchemier, Béatrice Garcin, et al.
Journal of Neuroscience Methods|June 2, 2022
A temporal classification method based on behavior time series data in patients with behavioral variant of frontotemporal dementia and apathyCaroline Peltier, François-Xavier Lejeune, Lars G T Jorgensen, et al.
The American Journal of Cardiology|May 21, 2008
Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II)Ahmed A Khattab, Joost Daemen, Gert Richardt, et al.
The New England Journal of Medicine|March 2, 2012
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosisClaire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, et al.
The New England Journal of Medicine|September 17, 2010
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosisSrdan Verstovsek, Hagop Kantarjian, Ruben A Mesa, et al.
JAMA Neurology|December 18, 2013
DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypesPaola Caroppo, Isabelle Le Ber, Fabienne Clot, et al.
Nature Communications|January 24, 2018
Southern Ocean warming and Wilkes Land ice sheet retreat during the mid-MioceneFrancesca Sangiorgi, Peter K Bijl, Sandra Passchier, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Trials|November 22, 2019
Testing the therapeutic effects of transcranial direct current stimulation (tDCS) in semantic dementia: a double blind, sham controlled, randomized clinical trialClara Sanches, Richard Levy, Sarah Benisty, et al.
Cancer Research Communications|March 16, 2023
Repurposing Azacitidine and Carboplatin to Prime Immune Checkpoint Blockade-resistant Melanoma for Anti-PD-L1 RechallengeAndre van der Westhuizen, Megan Lyle, Moira C Graves, et al.
The Journal of Prevention of Alzheimer'S Disease|January 29, 2025
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study: Smartphone App for MCI DetectionJulien Dumurgier, Claire Paquet, Jacques Hugon, et al.
Brain : a Journal of Neurology|April 15, 2016
Reasoning by analogy requires the left frontal pole: lesion-deficit mapping and clinical implicationsMarika Urbanski, Marie-Laure Bréchemier, Béatrice Garcin, et al.
Journal of Neuroscience Methods|June 2, 2022
A temporal classification method based on behavior time series data in patients with behavioral variant of frontotemporal dementia and apathyCaroline Peltier, François-Xavier Lejeune, Lars G T Jorgensen, et al.
The American Journal of Cardiology|May 21, 2008
Impact of body mass index on the one-year clinical outcome of patients undergoing multivessel revascularization with sirolimus-eluting stents (from the Arterial Revascularization Therapies Study Part II)Ahmed A Khattab, Joost Daemen, Gert Richardt, et al.
The New England Journal of Medicine|March 2, 2012
JAK inhibition with ruxolitinib versus best available therapy for myelofibrosisClaire Harrison, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali, et al.
The New England Journal of Medicine|September 17, 2010
Safety and efficacy of INCB018424, a JAK1 and JAK2 inhibitor, in myelofibrosisSrdan Verstovsek, Hagop Kantarjian, Ruben A Mesa, et al.
JAMA Neurology|December 18, 2013
DCTN1 mutation analysis in families with progressive supranuclear palsy-like phenotypesPaola Caroppo, Isabelle Le Ber, Fabienne Clot, et al.
Nature Communications|January 24, 2018
Southern Ocean warming and Wilkes Land ice sheet retreat during the mid-MioceneFrancesca Sangiorgi, Peter K Bijl, Sandra Passchier, et al.
Pageof 15